OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Treating Adult Acute Lymphocytic Leukemia in 2016

home / insights / acute-lymphocytic-leukemia
Overview on Management of Acute Lymphoblastic Leukemia

EP. 1: Overview on Management of Acute Lymphoblastic Leukemia

December 29th 2015
Acute Lymphoblastic Leukemia Patient Population

EP. 2: Acute Lymphoblastic Leukemia Patient Population

December 29th 2015
Induction and Post-Induction Therapy for Adult ALL

EP. 3: Induction and Post-Induction Therapy for Adult ALL

December 29th 2015
Targeted and Chemotherapy Treatment Options in ALL

EP. 4: Targeted and Chemotherapy Treatment Options in ALL

December 29th 2015
Minimal Residual Disease in ALL

EP. 5: Minimal Residual Disease in ALL

December 29th 2015
Allogeneic Stem Cell Transplant in ALL

EP. 6: Allogeneic Stem Cell Transplant in ALL

December 29th 2015
MRD Monitoring in Acute Lymphoblastic Leukemia

EP. 7: MRD Monitoring in Acute Lymphoblastic Leukemia

December 29th 2015
Salvage Therapy in Acute Lymphoblastic Leukemia

EP. 8: Salvage Therapy in Acute Lymphoblastic Leukemia

December 29th 2015
Using Blinatumomab in Acute Lymphoblastic Leukemia

EP. 9: Using Blinatumomab in Acute Lymphoblastic Leukemia

December 29th 2015
Adverse Event Profile of Blinatumomab in ALL

EP. 10: Adverse Event Profile of Blinatumomab in ALL

December 29th 2015
Optimizing Blinatumomab Use in Acute Lymphoblastic Leukemia

EP. 11: Optimizing Blinatumomab Use in Acute Lymphoblastic Leukemia

December 29th 2015
CAR T-Cell Immunotherapy in Acute Lymphoblastic Leukemia

EP. 12: CAR T-Cell Immunotherapy in Acute Lymphoblastic Leukemia

December 29th 2015
Emerging Therapeutic Alternatives in Acute Lymphoblastic Leukemia

EP. 13: Emerging Therapeutic Alternatives in Acute Lymphoblastic Leukemia

December 29th 2015

Latest Conference Coverage

Real-World Data Confirm Efficacy of Axi-cel Across Patient-Related Factors in R/R LBCL

Bexobrutideg Is Safe, Shows Early Efficacy in Relapsed/Refractory CLL

Asciminib Shows Superior Tolerability Over Nilotinib in Newly Diagnosed CML in Chronic Phase

ESAs or Danazol Plus Ruxolitinib Produce Comparable Spleen and Symptom Response Rates in Myelofibrosis With Anemia

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact